GoalVest Advisory LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

GoalVest Advisory LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 3,248 shares of the healthcare conglomerate’s stock after acquiring an additional 124 shares during the period. GoalVest Advisory LLC’s holdings in UnitedHealth Group were worth $1,899,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $27,000. Macroview Investment Management LLC lifted its holdings in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at about $31,000. Global Wealth Strategies & Associates lifted its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. Finally, Signature Resources Capital Management LLC lifted its holdings in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.2 %

NYSE:UNH opened at $592.23 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company’s 50 day moving average is $582.84 and its two-hundred day moving average is $549.52. The company has a market cap of $545.02 billion, a PE ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the business posted $6.56 EPS. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Truist Financial reissued a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Stephens cut their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. UBS Group cut their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.